<DOC>
	<DOC>NCT01712373</DOC>
	<brief_summary>The purpose of this study was to evaluate the efficacy and safety of Ginseng in treatment of fatigue and Quality of Life of MS patients.</brief_summary>
	<brief_title>Ginseng in Treatment of Fatigue in Multiple Sclerosis</brief_title>
	<detailed_description>Multiple Sclerosis (MS) is one of the most common non-traumatic causes of disability in the world. It is a chronic inflammatory and demyelinating disorder of the Central Nervous System (CNS) which affects individuals in the productive ages and causes a large burden for years to come. Fatigue is a common complaint and one of the least understood symptoms of MS</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<criteria>definite diagnosis of relapsingremitting MS (RRMS) by the MacDonald criteria with a baseline of Expanded Disability Status Score (EDSS)of less than 5.0 prior use of ginseng or any other tonic agents, glucocorticoids, warfarin, digoxin, aspirin, furosemide, caffeine, ephedra and antiplatelet agents within one month prior to enrollment; Pregnancy or lactation; history of renal failure; and, lack of appropriate adherence to the study protocol.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Multiple sclerosis</keyword>
	<keyword>Ginseng</keyword>
	<keyword>Fatigue</keyword>
	<keyword>Quality of life</keyword>
</DOC>